Aardvark Therapeutics, Inc. - AARD

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$48.45M
QoQ value delta ($000)
-$92.52M (-65.63%)
Implied price effect (QoQ)
-66.47%
Shares
Total shares
11,015,839
QoQ shares delta
+268,416 (+2.5%)
Total shares held by funds (by quarter)

Market chart (AARD)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 80 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Decheng Capital LLC 14,768 3,917,299 2.23%
VANGUARD GROUP INC 9,416 717,430 0.0%
CITADEL ADVISORS LLC 4,884 1,295,677 0.0%
Laurion Capital Management LP 3,899 1,034,459 0.17%
BlackRock, Inc. 2,987 792,571 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 2,088 554,101 0.0%
Tetragon Partners GP Ltd 1,193 316,621 0.23%
GEODE CAPITAL MANAGEMENT, LLC 1,166 309,449 0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,131 300,000 0.0%
STATE STREET CORP 751 199,322 0.0%
TWO SIGMA INVESTMENTS, LP 615 163,355 0.0%
UBS Group AG 595 157,888 0.0%
AQR CAPITAL MANAGEMENT LLC 507 134,495 0.0%
MILLENNIUM MANAGEMENT LLC 370 98,334 0.0%
TWO SIGMA ADVISERS, LP 343 26,200 0.0%
NORTHERN TRUST CORP 334 88,599 0.0%
VANGUARD FIDUCIARY TRUST CO 313 83,210 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 283 75,149 0.0%
Woodline Partners LP 273 72,429 0.0%
RENAISSANCE TECHNOLOGIES LLC 266 70,792 0.0%
CANTOR FITZGERALD, L. P. 251 66,682 0.0%
CITIGROUP INC 174 46,265 0.0%
Cresset Asset Management, LLC 163 43,259 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 126 33,684 0.01%
PRELUDE CAPITAL MANAGEMENT, LLC 115 30,637 0.01%